Apyx Medical Corporation's Participation in Investor Events

Apyx Medical Corporation's Participation in Investor Events

Apyx Medical Corporation (NASDAQ: APYX) is excited to share details about its upcoming participation in notable investor conferences. As a leading innovator in advanced energy technology, Apyx Medical, known for its Renuvion and AYON Body Contouring System, is poised to showcase its groundbreaking products and engage with investors soon. This announcement comes as the company prepares for vital sessions that allow it to connect with market stakeholders.

Upcoming Conferences Schedule

During the month of November, Apyx Medical will participate in two significant conferences that focus on advancements in medical technology and market insights:

Craig-Hallum Alpha Select Conference

This premier conference is set for November 18. The event will take place at the Sheraton NY Times Square Hotel and will feature streamlined one-on-one meetings aimed at fostering direct communication between executives and investors. Charles Goodwin, President and CEO, along with CFO Matt Hill, will join these discussions, presenting Apyx’s strategic vision.

Canaccord Genuity MedTech, Diagnostics and Digital Health Forum

The second event, scheduled for November 20 at the Westin NY Grand Central, will also follow a one-on-one meeting format. Apyx Medical aims to engage with potential and existing investors to highlight its growth trajectory and discuss its innovative technologies in the medical field. Interested parties are encouraged to reach out to representatives from Craig Hallum and Canaccord Genuity to secure a meeting.

About Apyx Medical Corporation

Apyx Medical Corporation is at the forefront of medical technology innovation, primarily focusing on solutions that enhance surgical outcomes. The company offers revolutionary products that harness helium plasma technology. Renuvion is specifically tailored for cosmetic surgery, allowing surgeons to deliver controlled thermal energy to tissues effectively. The AYON Body Contouring System is a versatile, FDA-cleared platform that integrates various surgical features for comprehensive body contouring.

Innovative Product Offerings

Apyx Medical's technologies include Renuvion and J-Plasma, recognized for their efficiency and effectiveness as evidenced by extensive clinical documentation. The AYON system represents a significant advancement in body contouring, allowing for fat removal and tissue contraction simultaneously, delivering superior outcomes for patients. These innovations reflect Apyx's commitment to improving surgical procedures and patient satisfaction.

Investor Relations

For inquiries related to investor relations, Jeremy Feffer, Managing Director at LifeSci Advisors, is the designated contact for Apyx Medical. Those interested in connecting can reach him via phone at 212-915-2568 or through email.

Frequently Asked Questions

What is the main focus of Apyx Medical Corporation?

Apyx Medical focuses on developing advanced energy technology solutions for cosmetic and surgical applications, specifically through its Renuvion and AYON systems.

When are the upcoming investor conferences for Apyx Medical?

Apyx Medical will participate in the Craig-Hallum Alpha Select Conference on November 18 and the Canaccord Genuity MedTech, Diagnostics and Digital Health Forum on November 20.

Who will represent Apyx Medical at the conferences?

Charles Goodwin, President and CEO, and Matt Hill, CFO, will represent Apyx Medical at both conferences.

How can investors request meetings with Apyx Medical?

Investors interested in meeting with Apyx Medical representatives can contact their Craig Hallum and Canaccord Genuity representatives for arrangements.

Where can I find more information about Apyx Medical’s products?

For additional details about Apyx Medical’s innovative products, visit the official website at www.ApyxMedical.com.

About The Author

Hi there I'm 38-year-old author and financial consultant Owen Jenkins. Having worked in the financial sector for more than ten years, I am well-versed in the subtleties and complexity that mold our financial environment. Following a degree in finance, I worked in a number of financial institutions honing my abilities in market analysis, financial planning, and investment strategies.

My love is teaching others about investing and personal finance. My goal in writing many books and articles has been to demystify financial ideas and give readers the information they need to make wise financial decisions. I write with a direct, useful style that emphasizes doable suggestions for daily living.

Along with writing, I lead webinars and seminars where I impart knowledge on how to successfully negotiate the financial world. I also write for financial journals and show up as a guest expert on financial news programs a lot. Whether they are new to investing or want to improve their approach, my mission is to enable people to take charge of their financial futures.

Beyond work, I like to hike, play the guitar, and spend time with my family. I think that balance is crucial and want to encourage people to strike a balance between their financial aspirations and their hobbies. I want to help people succeed and achieve financial security through my work, so having a good influence.

Contact Owen Jenkins privately here. Or send an email with ATTN: Owen Jenkins as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.